Cosmetic breast implants may adversely affect survival in women who develop breast cancer

April 30, 2013

Cosmetic breast implants seem to adversely affect the survival of women who are subsequently diagnosed with breast cancer, finds a small study published on BMJ website today.

The authors stress that these findings should be interpreted with caution as some studies did not adjust for other potential confounding factors. They call for further investigations into the effects of breast implants.

Cosmetic breast implants have become increasingly popular, but some studies have suggested that implants can make it more difficult to detect at an early stage because they create shadows on mammograms that can obscure some .

A team of researchers based in Canada wanted to find out whether the stage at which breast cancer is diagnosed - and post-diagnosis survival - differed between women with and without cosmetic breast implants.

First they analysed the results of 12 , all published after 1993 and conducted mainly in the US, northern Europe and Canada. They found that women with cosmetic breast implants had a 26% increased risk of being diagnosed at a later stage of breast cancer than women without implants.

They then analysed the results of a further five studies and found that women with cosmetic breast implants had a 38% greater risk of death from breast cancer than women without implants.

However, the authors warn that these findings "should be interpreted with caution as some studies included in the meta-analysis on survival did not adjust for potential confounders."

They point to some study limitations, but say "the accumulating evidence suggests that women with cosmetic breast implants who develop breast cancer have an increased risk of being diagnosed as having non-localized more frequently than do women with breast cancer who do not have implants."

Current evidence also suggests that cosmetic breast implants "adversely affect breast cancer specific survival following the diagnosis of such disease," they add.

"Further investigations are warranted into the long term effects of cosmetic on the detection and prognosis of breast cancer, adjusting for potential confounders," they conclude.

Explore further: Before deciding on breast implants, consider FDA precautions

More information: www.bmj.com/cgi/doi/10.1136/bmj.f2399

Related Stories

Before deciding on breast implants, consider FDA precautions

February 27, 2013
(HealthDay)—If you're thinking about getting breast implants, there are some things you need to know before you make your decision, according to the U.S. Food and Drug Administration.

Dutch women reimbursed for breast implant removals

January 26, 2012
Dutch women wanting to replace potentially defective breast implants made by now-defunct French company PIP will be paid back in full, the Dutch health insurance federation said Thursday.

20 cancer cases in French women with PIP implants: agency

December 30, 2011
French health authorities said Friday that 20 cases of cancer had been uncovered in women with allegedly faulty French-made breast implants but insisted there was still no proven link with the disease.

Some 8,000 French women have faulty breast implants removed

June 4, 2012
French health authorities said Monday that nearly 8,000 French women had followed a government recommendation to have faulty breast implants that sparked a global health scare removed.

Italy seeking women with French breast implants

December 22, 2011
(AP) -- Italy's health ministry on Thursday asked hospitals to track down women who received silicone breast implants made by a suspect French company due to concerns the implants may be unsafe.

Britain reviews data on French breast implants

December 31, 2011
Britain's health minister said Saturday he has ordered an urgent review of the data used to assess the risks of breast implants made by French firm PIP, after receiving "conflicting" information.

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.